Skip to main content
Review Article
Originally Published 24 October 2006
Free Access

Hypertrophic Obstructive Cardiomyopathy: Septal Ablation With Overlapping Sirolimus-Eluting and Covered Stents After Failed Alcoholization and Concomitant Coronary Artery Disease

A 61-year-old man with exertional dyspnea was diagnosed with hypertrophic obstructive cardiomyopathy. The echocardiogram demonstrated an interventricular septum with a thickness of 18 mm, marked systolic anterior motion, and mitral regurgitation grade 3. The left ventricular outflow tract (LVOT) gradient was 100 mm Hg. The patient was treated with percutaneous transluminal septal myocardial alcohol ablation, resulting in a residual LVOT gradient of 20 mm Hg. Mild coronary artery disease of the proximal left anterior descending coronary artery (LAD) and the first diagonal branch (D1) (40% diameter stenosis by quantitative coronary angiography) was left untreated.
The patient remained asymptomatic for 6 months and then again had development of exertional dyspnea. The echocardiogram revealed relapse of the LVOT gradient (80 mm Hg). Repeat percutaneous transluminal septal myocardial alcohol ablation was planned. The invasive LVOT gradient was 77 mm Hg. Coronary angiography demonstrated progression of the disease of both lesions in the LAD and D1 (70% by quantitative coronary angiography). Because of the concomitant coronary artery disease, the treatment plan was changed. The LAD and the D1 were treated with sirolimus-eluting stent implantation (Figure 1A). Instead of injecting ethanol, a polytetrafluoroethylene-covered stent was implanted within the borders of the sirolimus-eluting stent over the ostium of the septal artery (Figure 1B). The procedure resulted in occlusion of the septal branch and immediate reduction of the LVOT gradient to 12 mm Hg (Figure 1C). The creatine kinase level rose to 789 IU/L. At 12 months’ follow-up, the patient remained asymptomatic. Repeat angiography revealed no restenosis (Figure 1D), and intravascular ultrasound showed complete absence of neointima formation (Figure 1F and 1G). Furthermore, no signs of septal collateralization through the right coronary artery were noted (Figure 1E). There was no rest gradient. Multislice computed tomography imaging demonstrated good stent patency (Figure 2), and magnetic resonance imaging with gadolinium demonstrated the region of the infarcted interventricular septum (Figure 3). Septal reperfusion through collaterals leading to treatment failure after occlusion with covered stents has been previously reported.1,2 In our case, this probably was prevented by myocardial fibrosis and destruction of the microcirculation after the initial alcoholization.
Figure 1. Angiographic images demonstrating the placement of a 3.5 × 28-mm, sirolimus-eluting stent (SES) (white arrowheads) in the LAD over the septal branch (SB) (white arrow) (A); the placement of a 3.5 × 12-mm, polytetrafluoethylene-covered stent (black arrowheads) within the SES over the ostium of the septal branch (B); the postprocedural result with complete absence of opacification of the SB (white arrow) (C); and the 12-month follow-up result with no signs of restenosis and persistent SB occlusion (D). E, Follow-up angiography of the right coronary artery (insert) depicting the SES (white arrowheads), the polytetrafluoethylene-covered stent (black arrowheads), and the absence of collateral formation or SB opacification (white arrow) during the delayed phase of contrast dye injection. The patency of the stented LAD without neointima formation was also affirmed by intravascular ultrasound both in the SES-only region (F, single-strut layer) and in the region of overlapping stents (G, triple-strut layer).
Figure 2. Sixty-four–slice computed tomography angiogram. A, Volume-rendered image demonstrating the stented LAD (black arrow) and D1 (white arrow). B, Multiplanar reconstructed image showing the sirolimus-eluting stent (white arrowheads) and the polytetrafluoethylene-covered stent (black arrowheads) in the LAD and the sirolimus-eluting stent in the D1 (white arrow). The lumen within the stents is clearly visible without signs of neointima formation.
Figure 3. Magnetic resonance imaging (1.5 Tesla) depicting the infarcted area (black arrows pointing at bright region) of the septum in 4-chamber (A), left ventricular outflow tract (B), and short-axis (C) views using an inversion-recovery T1-weighted gradient echo sequence 15 minutes after administration of 0.2 mmol/kg gadolinium-pentetic acid. RA indicates right atrium; LA, left atrium; LV, left ventricle; RV, right ventricle; and Ao, aortic root.

Disclosures

None.

References

1.
Fifer MA, Yoerger DM, Picard MH, Vlahakes GJ, Palacios IF. Covered stent septal ablation for hypertrophic obstructive cardiomyopathy: initial success but ultimate failure resulting from collateral formation. Circulation. 2003; 107: 3248–3249.
2.
Anzuini A, Uretsky BF. Covered stent septal ablation for hypertrophic obstruction cardiomyopathy. Circulation. 2004; 109: e6.

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Information & Authors

Information

Published In

Go to Circulation
Go to Circulation
Circulation
Pages: e553 - e555
PubMed: 17060391

History

Published online: 24 October 2006
Published in print: 24 October 2006

Permissions

Request permissions for this article.

Subjects

Authors

Affiliations

Georgios Sianos, MD, PhD
From Thoraxcenter, Department of Cardiology (G.S., M.I.P., E.C.V., J.T.L., T.B., F.J.T.C., P.W.S.) and Department of Radiology (E.C.V., T.B.), Erasmus Medical Center, Rotterdam, The Netherlands.
Michail I. Papafaklis, MD
From Thoraxcenter, Department of Cardiology (G.S., M.I.P., E.C.V., J.T.L., T.B., F.J.T.C., P.W.S.) and Department of Radiology (E.C.V., T.B.), Erasmus Medical Center, Rotterdam, The Netherlands.
Eleni C. Vourvouri, MD, PhD
From Thoraxcenter, Department of Cardiology (G.S., M.I.P., E.C.V., J.T.L., T.B., F.J.T.C., P.W.S.) and Department of Radiology (E.C.V., T.B.), Erasmus Medical Center, Rotterdam, The Netherlands.
Jurgen T. Ligthart, BSc
From Thoraxcenter, Department of Cardiology (G.S., M.I.P., E.C.V., J.T.L., T.B., F.J.T.C., P.W.S.) and Department of Radiology (E.C.V., T.B.), Erasmus Medical Center, Rotterdam, The Netherlands.
Timo Baks, MD
From Thoraxcenter, Department of Cardiology (G.S., M.I.P., E.C.V., J.T.L., T.B., F.J.T.C., P.W.S.) and Department of Radiology (E.C.V., T.B.), Erasmus Medical Center, Rotterdam, The Netherlands.
Folkert J. Ten Cate, MD, PhD
From Thoraxcenter, Department of Cardiology (G.S., M.I.P., E.C.V., J.T.L., T.B., F.J.T.C., P.W.S.) and Department of Radiology (E.C.V., T.B.), Erasmus Medical Center, Rotterdam, The Netherlands.
Patrick W. Serruys, MD, PhD
From Thoraxcenter, Department of Cardiology (G.S., M.I.P., E.C.V., J.T.L., T.B., F.J.T.C., P.W.S.) and Department of Radiology (E.C.V., T.B.), Erasmus Medical Center, Rotterdam, The Netherlands.

Notes

Correspondence to Georgios Sianos, MD, PhD, FESC, Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. E-mail [email protected]

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

  1. Effective treatment of hypertrophic cardiomyopathy with left ventricular outflow tract obstruction using a covered stent, BMJ Case Reports, 15, 12, (e250929), (2022).https://doi.org/10.1136/bcr-2022-250929
    Crossref
  2. Unstable angina complicated with dynamic left ventricular outflow tract obstruction, Journal of Cardiology Cases, 23, 4, (181-188), (2021).https://doi.org/10.1016/j.jccase.2021.01.013
    Crossref
  3. Very long-term outcome of coronary covered stents: a report from the SCAAR registry, EuroIntervention, 14, 16, (1660-1667), (2019).https://doi.org/10.4244/EIJ-D-18-00855
    Crossref
  4. Contemporary techniques for catheter-based intervention for hypertrophic obstructive cardiomyopathy, EuroIntervention, 12, X, (X44-X47), (2016).https://doi.org/10.4244/EIJV12SXA9
    Crossref
  5. Aortic Valve Valvuloplasty, Percutaneous Treatment of Cardiovascular Diseases in Women, (103-110), (2016).https://doi.org/10.1007/978-3-319-39611-8_7
    Crossref
  6. Patterns of Left Ventricular Remodeling in Aortic Stenosis: Therapeutic Implications, Current Treatment Options in Cardiovascular Medicine, 17, 7, (2015).https://doi.org/10.1007/s11936-015-0391-0
    Crossref
  7. Low Gradient Aortic Stenosis, Current Treatment Options in Cardiovascular Medicine, 17, 5, (2015).https://doi.org/10.1007/s11936-015-0378-x
    Crossref
  8. Assessment of low-flow, low-gradient aortic stenosis: multimodality imaging is the key to success, EuroIntervention, 10, U, (U52-U60), (2014).https://doi.org/10.4244/EIJV10SUA8
    Crossref
  9. Management of aortic valve disease in the presence of left ventricular dysfunction, Expert Review of Cardiovascular Therapy, 8, 2, (259-268), (2014).https://doi.org/10.1586/erc.09.171
    Crossref
  10. Ejection Fraction/Velocity Ratio Identifies Prosthesis-Patient Mismatches in Patients With Aortic Bioprosthetic Valves and Left Ventricular Dysfunction, Journal of Ultrasound in Medicine, 28, 9, (1167-1174), (2009).https://doi.org/10.7863/jum.2009.28.9.1167
    Crossref
  11. See more
Loading...

View Options

View options

PDF and All Supplements

Download PDF and All Supplements

PDF/ePub

View PDF/ePub

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase access to this article for 24 hours

Hypertrophic Obstructive Cardiomyopathy
Circulation
  • Vol. 114
  • No. 17

Purchase access to this journal for 24 hours

Circulation
  • Vol. 114
  • No. 17
Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Media

Figures

Other

Tables

Share

Share

Share article link

Share

Comment Response